» Articles » PMID: 33177853

Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthy Obesity Phenotype: The Relevance of Insulin Resistance

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2020 Nov 12
PMID 33177853
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim was to evaluate 25(OH)D serum concentrations in metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) and its relation with biochemical and clinical parameters in both groups according to homeostatic model assessment-insulin resistance (HOMA-IR) definition of the obesity phenotypes.

Patients And Methods: Descriptive cross-sectional study was conducted with individuals of both genders. Anthropometric data [waist circumference, body mass index (BMI)] and metabolic parameters: blood glucose, glycated hemoglobin, insulin, lipid profile, calcium, phosphorus, parathyroid hormone (PTH) and high-sensitivity c-reactive protein (hs-CRP) and (25(OH)D) were obtained. The cutoff points for vitamin D deficiency and insufficiency were ≤20 and 21-29 ng/mL, respectively. Individuals were classified as MUHO according to HOMA-IR≥2.5.

Results: This study comprised 232 individuals with obesity (BMI≥35 kg/m; 42.6±4.7 kg/m). The MUHO phenotype was observed in 76.7% of the population. The mean values of glucose (<0.001), insulin (<0.001), HOMA-IR (<0.001), and triglycerides (=0.049) were significantly higher in the MUHO than in the MHO phenotype group. The mean value of 25(OH)D showed a significant difference between the MHO and MUHO phenotype groups (=0.011). Additionally, and in line, lower mean 25(OH)D values were found in the MUHO vs the MHO phenotype group in the deficiency (14.5±3.6 ng/mL/17.1±2.7 ng/mL, =0.004) and insufficiency (24.5±2.9 ng/mL/25.7±2.6 ng/mL, =0.077) 25(OH)D groups. An increase of 1 ng/mL of vitamin D increased in 1.051 (95% CI= 1.011-1.093, =0.012) the odds of the healthy phenotype.

Conclusion: The highest prevalence of inadequacy of serum concentrations of 25(OH)D and greater severity of this deficiency in individuals with MUHO phenotype were observed. Low serum concentrations of this vitamin were associated, mainly, with insulin resistance. Monitoring the nutritional status of vitamin D in individuals with obesity that present with MUHO phenotype may contribute to minimize the occurrence and aggravation of diseases associated with obesity.

Citing Articles

The association between white blood cell counts and metabolic health obesity among US adults.

Li Z, Yao Z, Liu Q Front Nutr. 2025; 12:1458764.

PMID: 39895838 PMC: 11784339. DOI: 10.3389/fnut.2025.1458764.


Relationship between the thrombospondin-1/Toll-like receptor 4 (TSP1/TLR4) pathway and vitamin D levels in obese and normal weight subjects with different metabolic phenotypes.

Khairy E, Saad A J Physiol Sci. 2023; 73(1):29.

PMID: 37964189 PMC: 10717613. DOI: 10.1186/s12576-023-00887-z.


Vitamin D in atherosclerosis and cardiovascular events.

Carbone F, Liberale L, Libby P, Montecucco F Eur Heart J. 2023; 44(23):2078-2094.

PMID: 36943351 PMC: 10281557. DOI: 10.1093/eurheartj/ehad165.

References
1.
Compher C, Badellino K, Boullata J . Vitamin D and the bariatric surgical patient: a review. Obes Surg. 2008; 18(2):220-4. DOI: 10.1007/s11695-007-9289-6. View

2.
Diaz-Ruiz A, Guzman-Ruiz R, Moreno N, Garcia-Rios A, Delgado-Casado N, Membrives A . Proteasome Dysfunction Associated to Oxidative Stress and Proteotoxicity in Adipocytes Compromises Insulin Sensitivity in Human Obesity. Antioxid Redox Signal. 2015; 23(7):597-612. PMC: 4554552. DOI: 10.1089/ars.2014.5939. View

3.
Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. DOI: 10.1001/archinte.168.15.1617. View

4.
Bluher M . Are there still healthy obese patients?. Curr Opin Endocrinol Diabetes Obes. 2012; 19(5):341-6. DOI: 10.1097/MED.0b013e328357f0a3. View

5.
Durward C, Hartman T, Nickols-Richardson S . All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J Obes. 2013; 2012:460321. PMC: 3523154. DOI: 10.1155/2012/460321. View